2026 Q1 Portfolio Activity
In 2026 Q1, Integral Health Asset Management, LLC maintained a portfolio of 116 distinct positions. The most significant new addition was ASTRAZENECA PLC, now representing 2.36% of the total fund value. They heavily accumulated shares in CYTOKINETICS INC, increasing the position by 220.0%. Conversely, Integral Health Asset Management, LLC completely exited their position in MEDTRONIC PLC.
Position History
hover any row below to update
Loading…
Total Positions
116
Quarter
2026 Q1
Top Holding
INSM (11.7%)
Top 10 Concentration
44.5%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 116
Integral Health Asset Management, LLC Full Holdings List — 2026 Q1
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
INSM
INSMED INC
|
Healthcare | 11.73% | 10.80% |
#1
Prev: #1
|
8.5 |
—
|
250,000 | 20.0% |
P
S
|
1,500,000 | $245,280,000 | 2020 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
RVMD
REVOLUTION MEDI...
|
Healthcare | 6.98% | 4.75% |
#2
Prev: #2
|
6.8 |
—
|
300,000 | 25.0% |
P
S
|
1,500,000 | $145,875,000 | 2023 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CYTK
CYTOKINETICS IN...
|
Healthcare | 5.04% | 4.42% |
#3
1
Prev: #4
|
5.0 |
—
|
200,000 | 14.3% |
P
S
|
1,600,000 | $105,456,000 | 2020 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
RVMD
PUT
REVOLUTION MEDI...
|
PUT Option | 3.49% | — |
#4
Prev: #—
|
5.4 |
—
|
750,000 | — |
NEW
|
750,000 | $72,937,500 | 2023 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CYTK
CALL
CYTOKINETICS IN...
|
CALL Option | 3.15% | 1.58% |
#5
12
Prev: #17
|
4.8 |
—
|
500,000 | 100.0% |
P
S
|
1,000,000 | $65,910,000 | 2020 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
REGN
REGENERON PHARM...
|
Healthcare | 3.14% | 4.02% |
#6
1
Prev: #5
|
1.8 |
—
|
-20,000 | -19.0% |
P
S
|
85,000 | $65,674,400 | 2020 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
VERA
VERA THERAPEUTI...
|
Healthcare | 3.08% | 4.53% |
#7
4
Prev: #3
|
1.7 |
—
|
-200,000 | -11.1% |
P
S
|
1,600,000 | $64,368,000 | 2024 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CAH
CARDINAL HEALTH...
|
Healthcare | 2.73% | 2.04% |
#8
2
Prev: #10
|
3.6 |
—
|
70,000 | 35.0% |
P
S
|
270,000 | $57,053,700 | 2022 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ROIV
ROIVANT SCIENCE...
|
Healthcare | 2.65% | 0.92% |
#9
29
Prev: #38
|
4.1 |
—
|
1,150,000 | 135.3% |
P
S
|
2,000,000 | $55,400,000 | 2023 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
BTSG
BRIGHTSPRING HE...
|
Healthcare | 2.55% | 1.39% |
#10
11
Prev: #21
|
4.0 |
—
|
500,000 | 66.7% |
P
S
|
1,250,000 | $53,262,500 | 2024 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
RYTM
RHYTHM PHARMACE...
|
Healthcare | 2.50% | 2.52% |
#11
3
Prev: #8
|
3.5 |
—
|
125,000 | 26.3% |
P
S
|
600,000 | $52,182,000 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
MRK
MERCK & CO INC
|
Healthcare | 2.45% | 1.31% |
#12
14
Prev: #26
|
4.0 |
—
|
175,000 | 70.0% |
P
S
|
425,000 | $51,123,250 | 2020 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
EWTX
EDGEWISE THERAP...
|
Healthcare | 2.41% | 1.85% |
#13
1
Prev: #12
|
3.0 |
—
|
100,000 | 6.7% |
P
S
|
1,600,000 | $50,400,000 | 2024 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
AZNCF
ASTRAZENECA PLC
|
Unknown | 2.36% | — |
#14
Prev: #—
|
4.4 |
—
|
250,000 | — |
NEW
|
250,000 | $49,305,000 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
RVMD
CALL
REVOLUTION MEDI...
|
CALL Option | 2.33% | — |
#15
Prev: #—
|
4.4 |
—
|
500,000 | — |
NEW
|
500,000 | $48,625,000 | 2023 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ALHC
ALIGNMENT HEALT...
|
Healthcare | 2.17% | 2.16% |
#16
7
Prev: #9
|
2.9 |
—
|
375,000 | 17.0% |
P
S
|
2,575,000 | $45,371,500 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
NVS
NOVARTIS AG
|
Healthcare | 1.83% | 1.71% |
#17
3
Prev: #14
|
1.7 |
—
|
no change | no change |
P
S
|
250,000 | $38,187,500 | 2020 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
BSX
BOSTON SCIENTIF...
|
Healthcare | 1.65% | 1.07% |
#18
13
Prev: #31
|
3.7 |
—
|
325,000 | 144.4% |
P
S
|
550,000 | $34,512,500 | 2019 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
LFST
LIFESTANCE HEAL...
|
Healthcare | 1.31% | 1.05% |
#19
14
Prev: #33
|
3.0 |
—
|
1,300,000 | 43.3% |
P
S
|
4,300,000 | $27,391,000 | 2021 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ASND
ASCENDIS PHARMA...
|
Healthcare | 1.26% | 0.95% |
#20
17
Prev: #37
|
3.0 |
—
|
25,000 | 27.8% |
P
S
|
115,000 | $26,303,950 | 2025 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
SRRK
SCHOLAR ROCK HL...
|
Healthcare | 1.18% | 0.66% |
#21
29
Prev: #50
|
3.5 |
—
|
200,000 | 66.7% |
P
S
|
500,000 | $24,580,000 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ELV
ELEVANCE HEALTH...
|
Healthcare | 1.05% | 1.04% |
#22
12
Prev: #34
|
2.9 |
—
|
15,000 | 25.0% |
P
S
|
75,000 | $21,956,250 | 2020 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CNC
CENTENE CORP DE...
|
Healthcare | 1.02% | 1.33% |
#23
1
Prev: #24
|
1.4 |
—
|
no change | no change |
P
S
|
650,000 | $21,281,000 | 2019 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
BBIO
BRIDGEBIO PHARM...
|
Healthcare | 0.98% | — |
#24
Prev: #—
|
3.9 |
—
|
275,000 | — |
NEW
|
275,000 | $20,421,500 | 2023 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
MLYS
MINERALYS THERA...
|
Healthcare | 0.97% | 1.35% |
#25
2
Prev: #23
|
1.4 |
—
|
no change | no change |
P
S
|
750,000 | $20,317,500 | 2024 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
NBIX
NEUROCRINE BIOS...
|
Healthcare | 0.95% | 1.06% |
#26
6
Prev: #32
|
1.4 |
—
|
no change | no change |
P
S
|
150,000 | $19,761,000 | 2019 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
GKOS
GLAUKOS CORP
|
Healthcare | 0.90% | 1.82% |
#27
14
Prev: #13
|
0.4 |
—
|
-150,000 | -46.2% |
P
S
|
175,000 | $18,840,500 | 2020 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ARWR
ARROWHEAD PHARM...
|
Healthcare | 0.90% | 0.33% |
#28
38
Prev: #66
|
3.4 |
—
|
200,000 | 200.0% |
P
S
|
300,000 | $18,810,000 | 2020 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
VRTX
VERTEX PHARMACE...
|
Healthcare | 0.85% | — |
#29
Prev: #—
|
3.8 |
—
|
40,000 | — |
NEW
|
40,000 | $17,861,600 | 2021 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ORIC
ORIC PHARMACEUT...
|
Healthcare | 0.85% | 0.49% |
#30
29
Prev: #59
|
2.3 |
—
|
200,000 | 16.7% |
P
S
|
1,400,000 | $17,738,000 | 2025 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ALMS
ALUMIS INC
|
Healthcare | 0.84% | — |
#31
Prev: #—
|
3.8 |
—
|
800,000 | — |
NEW
|
800,000 | $17,624,000 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
FMS
FRESENIUS MEDIC...
|
Healthcare | 0.84% | 0.77% |
#32
14
Prev: #46
|
2.3 |
—
|
125,000 | 19.2% |
P
S
|
775,000 | $17,484,000 | 2024 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ISRG
INTUITIVE SURGI...
|
Healthcare | 0.77% | 3.09% |
#33
26
Prev: #7
|
0.3 |
—
|
-75,000 | -68.2% |
P
S
|
35,000 | $16,134,650 | 2020 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
QURE
UNIQURE NV
|
Healthcare | 0.70% | 1.07% |
#34
5
Prev: #29
|
1.3 |
—
|
no change | no change |
P
S
|
900,000 | $14,715,000 | 2019 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
TARS
TARSUS PHARMACE...
|
Healthcare | 0.67% | 0.81% |
#35
10
Prev: #45
|
1.3 |
—
|
no change | no change |
P
S
|
200,000 | $14,030,000 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
GILD
GILEAD SCIENCES...
|
Healthcare | 0.67% | — |
#36
Prev: #—
|
3.8 |
—
|
100,000 | — |
NEW
|
100,000 | $13,937,000 | 2022 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
LLY
ELI LILLY & CO
|
Healthcare | 0.66% | 1.07% |
#37
7
Prev: #30
|
0.3 |
—
|
-5,000 | -25.0% |
P
S
|
15,000 | $13,796,550 | 2019 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
EW
EDWARDS LIFESCI...
|
Healthcare | 0.65% | 1.38% |
#38
16
Prev: #22
|
0.3 |
—
|
-155,000 | -47.7% |
P
S
|
170,000 | $13,613,600 | 2020 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
MLYS
CALL
MINERALYS THERA...
|
CALL Option | 0.65% | 0.45% |
#39
21
Prev: #60
|
3.3 |
—
|
250,000 | 100.0% |
P
S
|
500,000 | $13,545,000 | 2024 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
COGT
COGENT BIOSCIEN...
|
Healthcare | 0.64% | — |
#40
Prev: #—
|
3.8 |
—
|
350,000 | — |
NEW
|
350,000 | $13,471,500 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ELAN
ELANCO ANIMAL H...
|
Healthcare | 0.63% | 0.28% |
#41
28
Prev: #69
|
3.3 |
—
|
300,000 | 120.0% |
P
S
|
550,000 | $13,161,500 | 2023 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
MDGL
MADRIGAL PHARMA...
|
Healthcare | 0.63% | — |
#42
Prev: #—
|
3.8 |
—
|
25,000 | — |
NEW
|
25,000 | $13,086,750 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
PRAX
PRAXIS PRECISIO...
|
Healthcare | 0.62% | 0.59% |
#43
12
Prev: #55
|
1.2 |
—
|
no change | no change |
P
S
|
40,000 | $12,887,600 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
DNTH
DIANTHUS THERAP...
|
Healthcare | 0.60% | 0.56% |
#44
12
Prev: #56
|
0.2 |
—
|
-125,000 | -45.5% |
P
S
|
150,000 | $12,588,000 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
RGNX
REGENXBIO INC
|
Healthcare | 0.60% | 0.86% |
#45
4
Prev: #41
|
2.7 |
—
|
300,000 | 25.0% |
P
S
|
1,500,000 | $12,570,000 | 2021 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
DGX
QUEST DIAGNOSTI...
|
Healthcare | 0.56% | 0.65% |
#46
6
Prev: #52
|
0.2 |
—
|
-15,000 | -20.0% |
P
S
|
60,000 | $11,758,800 | 2019 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
XENE
XENON PHARMACEU...
|
Healthcare | 0.56% | — |
#47
Prev: #—
|
3.7 |
—
|
200,000 | — |
NEW
|
200,000 | $11,630,000 | 2022 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ERAS
ERASCA INC
|
Healthcare | 0.54% | — |
#48
Prev: #—
|
3.7 |
—
|
700,000 | — |
NEW
|
700,000 | $11,326,000 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ANRO
ALTO NEUROSCIEN...
|
Healthcare | 0.54% | 0.33% |
#49
15
Prev: #64
|
2.7 |
—
|
125,000 | 33.3% |
P
S
|
500,000 | $11,240,000 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
BIIB
BIOGEN INC
|
Healthcare | 0.53% | 0.87% |
#50
10
Prev: #40
|
0.2 |
—
|
-40,000 | -40.0% |
P
S
|
60,000 | $10,999,800 | 2020 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 |
Showing 1-50 of 116 holdings